THE EFFECTIVENESS OF TELEPHARMACY INTERVENTION ON HYPERTENSIVE PATIENTS
Abstract
Telepharmacy is a pharmaceutical care provision through a remote interaction between patients and pharmacists that provides patient counseling on medication management and adherence especially on chronic diseases such as hypertension. The study aims to evaluate the effectiveness of telepharmacy intervention on hypertensive patients during the COVID-19 pandemic. The research employed a quantitative, quasi-experimental design utilizing a purposive sampling technique to assess the effectiveness of telepharmacy intervention on their blood pressure and medication adherence. Thirty (30) participants were examined and subjected to the study using Wilcoxon signed-rank t-test and Student’s t-test to compare and analyze the parameters before and after the interventions. The results showed that telepharmacy intervention manifested a significant difference in the level of effectiveness of the patient’s systolic profile (p=0.009), diastolic profile (p= 0.766), and medication adherence (p<.001) in the intervention conducted. Moreover, there was a significant difference between the patients subjected to the intervention (p=0.009) between the patients who did not receive any intervention (p=0.798). Correlations between the parameters showed a moderately high negative relationship (-0.678) between the telepharmacy intervention and the blood pressure and medication adherence (p<0.01) which was highly significant. This means that as medication adherence increases, blood pressure decreases. Therefore, the effect size of the telepharmacy intervention was effective in decreasing its systolic, controlled diastolic, and medication adherence. Nevertheless, telepharmacy intervention is not yet fully maximized in the Philippines which can be a potential use in delivering pharmaceutical care. Current findings clearly illustrate the desirability and efficacy of telepharmacy intervention that can be utilized in the accessibility of medications to hypertensive patients.
References
Pipo MMQ, Lelis MA, Javelona JQ. [Internet]. An observational study on the antihypertensive management of high-risk patients in the Philippines . [cited 2020Dec28]. Available from: https://www.pcp.org.ph/files/PJIM%20Vol53%20No3/An_Observational_Study_on_the_Antihypertensive_Management_of_High-Risk_Patients_in_the_Philippines.pdf
Siang TC, Hassali MA, Fen NC. The role of pharmacist in MANAGING hypertension in the community: Findings from a community based study. Indian Journal of Pharmaceutical Education and Research. 2019;53(3):553–61.
Albasari A, Sheppard JP, McManus RJ, McDonagh STJ, Omboni S, Clark CE. Effective detection and management of hypertension through Community pharmacy in England. The Pharmaceutical Journal. 2020;
Gums TH, Uribe L, Vander Weg MW, James P, Coffey C, Carter BL. Pharmacist intervention for blood pressure control: Medication intensification and adherence. Journal of the American Society of Hypertension. 2015;9(7):569–78.
Poudel A, Nissen L. Telepharmacy: A PHARMACIST’S perspective on the clinical benefits and challenges. Integrated Pharmacy Research and Practice. 2016;Volume 5:75–82. (JOURNAL ARTICLE, 2 authors)
Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: A key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Current Opinion in Cardiology. 2004;19(4):357–62.
Conn VS, Ruppar TM, Chase J-AD, Enriquez M, Cooper PS. Interventions to improve medication adherence in hypertensive patients: Systematic review and meta-analysis. Current Hypertension Reports. 2015;17(12).
Bhusal A, Jadhav P, Deshmukh Y. Assessment of medication adherence among hypertensive patients: A cross-sectional study. International Journal of Basic and Clinical Pharmacology. 2016;:1606–12.
Hamdidouche I, Jullien V, Boutouyrie P, Billaud E, Azizi M, Laurent S. Drug adherence in hypertension. Journal of Hypertension. 2017;35(6):1133–44.
Burnier M, Egan BM. Adherence in hypertension. Circulation Research. 2019;124(7):1124–40.
Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current situation of medication adherence in hypertension. Frontiers in Pharmacology. 2017;8.
Beevers G. ABC of Hypertension: The pathophysiology of hypertension. BMJ. 2001;322(7291):912–6.
Beevers G. ABC of hypertension: Blood pressure measurement. BMJ. 2001;322(7292):981–5.
Omboni S. Connected health in HYPERTENSION MANAGEMENT. Frontiers in Cardiovascular Medicine. 2019;6.
Cottrell E, Cox T, O’Connell P, Chambers R. Implementation of simple telehealth to manage hypertension in general practice: A service evaluation. BMC Family Practice. 2015;16(1).
Perdew C, Erickson K, Litke J. Innovative models for providing clinical pharmacy services to remote locations using clinical video telehealth. American Journal of Health-System Pharmacy. 2017;74(14):1093–8.
Omboni S, Tenti M. Telepharmacy for the management of CARDIOVASCULAR patients in the community. Trends in Cardiovascular Medicine. 2019;29(2):109–17.
Fensterheim LE, Gunn JG, Pokuta KL, Straszewski A, Marks A. Initial impact OF TELEPHARMACY on specialty medication adherence. Value in Health. 2015;18(3).
Mohamed Ibrahim O, Ibrahim RM, Abdel-Qader DH, Al Meslamani AZ, Al Mazrouei N. Evaluation of Telepharmacy services in light of covid-19. Telemedicine and e-Health. 2021;27(6):649–56.
Baldoni S, Amenta F, Ricci G. Telepharmacy services: Present status and FUTURE Perspectives: A review. Medicina. 2019;55(7):327.
Omboni S, Tenti M, Coronetti C. Physician–pharmacist collaborative practice and telehealth may transform hypertension management. Journal of Human Hypertension. 2018;33(3):177–87.
Ibrahim OM, Ibrahim RM, Z Al Meslamani A, Al Mazrouei N. Role of telepharmacy IN PHARMACIST counselling to CORONAVIRUS disease 2019 patients and MEDICATION dispensing errors. Journal of Telemedicine and Telecare. 2020;
Tan CS, Hassali MA, Neoh CF, Ming LC. Beliefs about medicine and medication adherence among hypertensive patients in the community setting. Drugs & Therapy Perspectives. 2020;36(8):358–67.
Abrahamse W. Research designs for measuring the effectiveness of interventions. Research Methods for Environmental Psychology. 2016;:291–306.
Aziz F, Malek S, Mhd Ali A, Wong MS, Mosleh M, Milow P. Determining hypertensive patients’ beliefs towards medication and associations with medication adherence using machine learning methods. PeerJ. 2020;8.
Singh S, Shankar R, Singh GP. Prevalence and associated risk factors of hypertension: A cross-sectional study in urban varanasi. International Journal of Hypertension. 2017;2017:1–10.
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control. Circulation. 2016;134(6):441–50. (JOURNAL ARTICLE, more than 6 authors)
Kang CD, Tsang PPM, Li WTL, Wang HHX, Liu KQL, Griffiths SM, et al. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong kong: A cross-sectional study. International Journal of Cardiology. 2015;182:250–7.
Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. New England Journal of Medicine. 2001;345(18):1291–7.
Campbell N, Ordunez P, Jaffe MG, Orias M, DiPette DJ, Patel P, et al. Implementing standardized performance indicators to improve hypertension control at both the population and healthcare organization levels. The Journal of Clinical Hypertension. 2017;19(5):456–61.
Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European society of Hypertension practice guidelines for home blood pressure monitoring. Journal of Human Hypertension. 2010;24(12):779–85.
Hatah E, Rahim N, Makmor-Bakry M, Mohamed Shah N, Mohamad N, Ahmad M, et al. Development and validation of MALAYSIA medication adherence assessment Tool (MyMAAT) for diabetic patients. PLOS ONE. 2020;15(11).
Hypertension [Internet]. World Health Organization. World Health Organization; [cited 2020Dec28]. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension
Holland K. High blood pressure (hypertension): Causes, symptoms, and more [Internet]. Healthline. Healthline Media; 2020 [cited 2020Dec30]. Available from: https://www.healthline.com/health/high-blood-pressure-hypertension
Adam Chesler PD& JA. Telepharmacy essential to MITIGATING Covid-19 pandemic [Internet]. Learn about Telepharmacy. 2020 [cited 2020Dec30]. Available from: https://blog.telepharm.com/telepharmacy-essential-to-mitigating-covid-19-pandemic
Noriega R. UP college of Pharmacy free Consultation up [Internet]. Manila Bulletin. 2020 [cited 2020Dec28]. Available from: https://mb.com.ph/2020/07/19/up-college-of-pharmacy-free-consultation-up/
Schladetzky Z. How telepharmacy IMPROVES care in MEDICALLY underserved areas [Internet]. Learn about Telepharmacy. 2017 [cited 2020Dec30]. Available from: https://blog.telepharm.com/how-telepharmacy-improves-care-in-medically-underserved-areas
Sabanovic S, Veladzic A, Ramic I, Mamatnazarova N. Review of application of telepharmacy solutions in the practice. 2020 9th Mediterranean Conference on Embedded Computing (MECO). 2020;
